Rupee weakness good news for IT firms but uncertainty on long-term impact

The recent depreciation of the rupee against the dollar is proving to be a tailwind for the Indian IT sector, which generates 50-60% of its revenues from the US market.

“For every 1% depreciation in the rupee, there is typically a 0.5% increase in revenue and about a 1.5% rise in profit. This quarter, the currency depreciation is expected to offset furlough impacts, leading to better performance,” said Pareekh Jain, CEO, Pareekh Consulting and EIIRTrend.

So far during the third quarter, the rupee has declined by approximately 108 paise against the dollar. Analysts forecast this will enhance IT firms’ margins by 30-50 basis points (bps).

Also ReadNoel N Tata: Tata Trusts’ new chairman set to navigate key decisions in 2025

But not everyone is enthused. “For firms like ours, which are largely offshore, rupee depreciation is a mixed bag,” said Venkatraman Narayanan, managing director and chief financial officer, Happiest Minds. “While revenues get a boost, we also face forward contract losses. Net-net, it helps offset some cost increases on a quarterly basis,” he said.

Additionally, a sharper decline in other global currencies such as the Chinese yuan, Japanese yen, and Mexican peso poses competitive pricing pressures. This year, the rupee has depreciated around 2% against the dollar, compared to a 27% slide in the Brazilian real, a 19% drop in the Mexican peso, and a 12% decline in the Japanese yen.

While a weaker rupee offers short-term advantages, analysts caution that its long-term impact on competitiveness is limited. Factors such as global currency trends and cost structures will influence the sustainability of gains.

Nonetheless, the combination of a favourable exchange rate and steady demand for digital transformation projects bodes well for the Indian IT sector.

“Despite currency pressures, the sector’s growth is underpinned by strong demand, particularly in cloud and AI-driven transformation projects,” said an industry analyst.

“The rupee depreciation will act as a margin tailwind, though the exact impact depends on factors such as hedging policies and offshoring levels,” an analyst from a domestic brokerage said.

While the rupee’s decline is a boon for revenues and profits, the net benefit varies across companies due to differences in hedging strategies, offshore revenue exposure, and margin profiles.

Adding to the sector’s optimism, Nasdaq-listed Accenture raised its fiscal 2025 annual revenue growth forecast to 4-7% from 3-6%.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s